News
CSL Behring's gene therapy Hemgenix for haemophilia B has been backed for reimbursement in England and Denmark.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback